Publication in Nature:
https://www.nature.com/articles/s41586-025-09326-y
Press release by Wellcome:
https://wellcome.org/news/chronic-pain-research-breakthrough-identifies-promising-drug-target
21 August 2025
Polyamines regulate key cellular processes and are linked to neurological disorders and pain. Prof David Bennett at NDCN performed a GWAS that identified SLC45A4 as associated with chronic pain. SLC45A4, a polyamine transporter enriched in sensory neurons, affects pain perception. Mice lacking SLC45A4 show reduced pain sensitivity, highlighting its potential as a pain therapy target. Dr Zhanru Yu and Prof Benedikt Kessler from the CMD participated in this study.
Publication in Nature:
https://www.nature.com/articles/s41586-025-09326-y
Press release by Wellcome:
https://wellcome.org/news/chronic-pain-research-breakthrough-identifies-promising-drug-target